Whitelab Genomics raised €9.8M in a Series A round in Sep 2022. The company is based in Paris, France. Investors in the round: Debiopharm Innovation Fund, Omnes Capital. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
